These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8547132)

  • 1. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies.
    Lavabre-Bertrand T; Exbrayat C; Liautard J; Gaillard JP; Baskevitch PP; Poujol N; Duperray C; Bourquard P; Brochier J
    Br J Haematol; 1995 Dec; 91(4):871-7. PubMed ID: 8547132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Barak V; Ginzburg M; Kalickman I; Polliack A
    Leuk Lymphoma; 1992 Aug; 7(5-6):431-8. PubMed ID: 1493444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
    Horiuchi S; Ampofo W; Koyanagi Y; Yamashita A; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
    Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/receptor interactions.
    Montero-Julian FA; Liautard J; Flavetta S; Romagné F; Gaillard JP; Brochier J; Klein B; Brailly H
    J Immunol Methods; 1994 Feb; 169(1):111-21. PubMed ID: 8133069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases.
    Doré P; Lelièvre E; Morel F; Brizard A; Fourcin M; Clemént C; Ingrand P; Daneski L; Gascan H; Wijdenes J; Gombert J; Preud'homme JL; Lecron JC
    Clin Exp Immunol; 1997 Jan; 107(1):182-8. PubMed ID: 9010274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Das Gupta A; Shah VI
    Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
    Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies.
    Pavlidis NA; Manoussakis MN; Germanidis GS; Moutsopoulos HM
    Med Pediatr Oncol; 1992; 20(1):26-31. PubMed ID: 1727208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
    Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
    Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of interleukin-2 receptors (alpha and beta chain) in mature lymphoid neoplasms.
    Nakase K; Kita K; Nasu K; Ueda T; Tanaka I; Shirakawa S; Tsudo M
    Am J Hematol; 1994 Jul; 46(3):179-83. PubMed ID: 7514848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin 6 receptor in biological fluids from human origin.
    Frieling JT; Sauerwein RW; Wijdenes J; Hendriks T; van der Linden CJ
    Cytokine; 1994 Jul; 6(4):376-81. PubMed ID: 7948745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-6 receptor levels in pleural effusions.
    Yokoyama A; Kohno N; Fujino S; Abe M; Ishida O; Hiwada K
    Respir Med; 1996 Jul; 90(6):329-32. PubMed ID: 8759474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer.
    Matsuzaki N; Neki R; Sawai K; Shimoya K; Okada T; Sakata M; Saji F; Koishihara Y; Ida N
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2912-7. PubMed ID: 7559874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
    Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome.
    Pamuk GE; Turgut B; Demir M; Vural O
    J Exp Clin Cancer Res; 2006 Dec; 25(4):537-41. PubMed ID: 17310845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.